long-acting integrase inhibitor protects macaques intrarectal simian/human immunodeficiency virus 
gsk1265744 gsk744 integrase strand-transfer inhibitor formulated long-acting la injectable suitable monthly quarterly clinical administration gsk744 la administered two time points weeks apart beginning week virus administration macaques challenged weekly weeks gsk744 la plasma concentrations achievable quarterly injections humans protected animals repeated low-dose challenges second experiment macaques given gsk744 la week virus administration challenged repeatedly infection occurred protection decreased time correlated plasma drug levels quarterly dosing schedule humans results suggest gsk744 la potentially decrease adherence problems associated daily preexposure prophylaxis prep 
